A Systematic Review of Intracranial Complications in Adults with Pott Puffy Tumor over Four Decades.
Alexandros DelidesEfstathia DavoutisEvangelos PanagoulisPavlos MaragkoudakisThomas NikolopoulosAlexander DelidesPublished in: Brain sciences (2023)
The purpose of this study is to investigate the risk factors of intracranial complications in adult patients with Pott Puffy Tumor (PPT). A systematic review was conducted of clinical studies from January 1983 to December 2022 that reported on PPT adult patients. The full-text articles were reviewed for the patients' ages, sex, cultured organisms, surgical procedures, clinical sequalae, and underlying diseases that may affect the onset of intracranial complications in PPT adult patients. A total of 106 studies were included. Medical data were reviewed for 125 patients (94 males, 31 females). The median age was 45 years. A total of 52% had comorbidities, mostly head trauma (24.5%), sinus/neurosurgical operations (22.4%), immunosuppression conditions (13.3%), diabetes mellitus (9.1%), cocaine use (7.1%), or dental infections (6.1%). A total of 28 cultures revealed Streptococcus (22.4%), 24 contained staphylococci (19.2%), and 22 cultures contained other pathogens (17.6%). An amount of 30.4% developed intracranial complications, with the most common being epidural abscesses or empyemas (55.3%), as well as subdural (15.7%) and extradural lesions (13.2%). Age, DM, and immunosuppression conditions are significantly associated with intracranial complications ( p < 0.001, p = 0.018 and p = 0.022, respectively). Streptococcus infection is associated with intracranial complications ( p = 0.001), although Staphylococcus and other microorganisms are not. Surgical intervention, mainly ESS, and broad-spectrum antibiotics remain the cornerstones of treatment.
Keyphrases
- risk factors
- optic nerve
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- type diabetes
- randomized controlled trial
- biofilm formation
- healthcare
- prognostic factors
- spinal cord injury
- staphylococcus aureus
- escherichia coli
- machine learning
- patient reported outcomes
- single cell
- smoking cessation
- optical coherence tomography
- antimicrobial resistance
- electronic health record